Back to search

United Kingdom· GB-APID-35166611000001104

Losartan 100mg tablets

A losartan product containing losartan, registered in United Kingdom by Milpharm Ltd. The same ATC class is registered in 19 of our 19 countries.

ATC C09CA01

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedLosartan 100mg tabletsATCC09CA01REGISTER NO.GB-APID-3516661100000…PACKS LISTED1CHECKEDSeptember 13, 2026

Where it is registered

Losartan is registered in 19 of 19 countries.

Countries holding a registration under ATC C09CA01 (losartan), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 11 of them publish a price we can compare per daily dose

Losartan · ATC C09CA01

19 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of losartan costs, country by country.

Normalised to the WHO defined daily dose (50 mg), the median price runs from $0.033 in United States to $0.61 in Switzerland — a ×19 gap.

  • 5 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail

Losartan · price per daily dose (50 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.61
  • IT Italy$0.30
  • ES Spain$0.17
  • FR France$0.10
  • US United States$0.033 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Losartan
Manufacturer
Milpharm Ltd
Country
United Kingdom (GB)
ATC code
C09CA01
ATC class
Losartan
Defined daily dose
50 mg, O
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 1

  • gtin
    8901175023219

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

431 interactions on record for losartan.

Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Losartan · interactions on record

431 records

  • 7 severe
  • 139 moderate
  • 2 minor
  • 198 info

Most severe, free to view

  • Potassium chlorideA12BA01severe
  • Potassium citrateA12BA02severe
  • Potassium gluconateA12BA05severe
  • Potassium chlorideB05XA01severe

85 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Losartan in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All losartan products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Cosaar, Losartan +pharma
  • Belgium · Cozaar, Loortan
  • Bulgaria · Лозап, Лориста
  • Cyprus · Cozaar, Losadrac
  • Czechia · Lorista, Lozap
  • Germany · Lorzaar Protect, Lorzaar Start
  • Denmark · Ancozan, Cozaar
  • Estonia · Lorista, Lozap
  • Spain · Cozaar, Cozaar Inicio
  • Finland · Cozaar, Losarion
  • France · Cozaar, Losartan Accord
  • Greece · Cozaar, Cozapert
  • Croatia · Cozaar, Lorista
  • Hungary · Arbartan, Cozaar
  • Ireland · Cozaar, Losartan Clonmel
  • Iceland · Cozaar, Losartan Medical Valley
  • Italy · Lastan, Lortaan
  • Lithuania · Lorista, Losartan Ingen Pharma
  • Luxembourg · Cozaar, Loortan
  • Latvia · Lorista
  • Malta · Losartan Potassium Aurobindo Pharma (Malta)
  • Netherlands · Cozaar, Entrizen
  • Norway · Cozaar, Losartan Krka
  • Poland · Cozaar, Lorista
  • Portugal · Cozaar, Cozaar Ic
  • Romania · Lorista, Losartan Arena
  • Sweden · Cozaar, Losartan Jubilant
  • Slovenia · Lorista
  • Slovakia · Lorista 100, Lorista 25

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e8b99bcf-1e36-409f-8e64-d326557e44a8
GET /v1/drugs/e8b99bcf-1e36-409f-8e64-d326557e44a8?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "35166611000001104",
  "desc": "Losartan 100mg tablets (Milpharm Ltd)",
  "form": "Oral tablet",
  "vpid": "42376711000001105",
  "source": "dmd",
  "vtm_id": "776577001",
  "strength": "100 mg",
  "substance": "Losartan",
  "ingredient": "Losartan potassium",
  "supplier_code": "3313311000001100"
}

See everything about losartan.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.